Gene Sequencing Giant Illumina Settles for $9.8M Over Product Vulnerabilities
Illumina has agreed to pay $9.8 million to resolve allegations that its products supplied to the US government contained cybersecurity vulnerabilities. This settlement highlights the importance of addressing security flaws in critical technology.